Codexis (CDXS) Capital Expenditures Growth (3y) (2013 - 2026)
Codexis (CDXS) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -12.25% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Codexis | 135.70 Mn | 70.56 Mn | 13.18 Mn | -38.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.04% |
| Dec 31, 2025 | 37.02% |
| Sep 30, 2025 | -49.97% |
| Jun 30, 2025 | -37.89% |
| Mar 31, 2025 | -37.29% |
| Dec 31, 2024 | -9.54% |
| Sep 30, 2024 | -29.25% |
| Jun 30, 2024 | 53.81% |
| Mar 31, 2024 | 24.97% |
| Dec 31, 2023 | 41.98% |
| Sep 30, 2023 | -56.40% |
| Jun 30, 2023 | 63.32% |
| Mar 31, 2023 | 49.43% |
| Dec 31, 2022 | -165.88% |
| Sep 30, 2022 | 56.25% |
| Jun 30, 2022 | 20.26% |
| Mar 31, 2022 | 229.70% |
| Dec 31, 2021 | 99.13% |
| Sep 30, 2021 | 58.62% |
| Jun 30, 2021 | -87.91% |